These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2248156)

  • 41. Transferring myoblasts in Duchenne dystrophy.
    Dubowitz V
    BMJ; 1992 Oct; 305(6858):844-5. PubMed ID: 1422391
    [No Abstract]   [Full Text] [Related]  

  • 42. The physiological evaluation of gene therapies of dystrophin-deficient muscles.
    Gillis JM; Deconinck N
    Adv Exp Med Biol; 1998; 453():411-6; discussion 417. PubMed ID: 9889852
    [No Abstract]   [Full Text] [Related]  

  • 43. Myoblast transfer in Duchenne muscular dystrophy.
    Karpati G; Ajdukovic D; Arnold D; Gledhill RB; Guttmann R; Holland P; Koch PA; Shoubridge E; Spence D; Vanasse M
    Ann Neurol; 1993 Jul; 34(1):8-17. PubMed ID: 8517684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pathobiogenetic concept of Duchenne muscular dystrophy following the discovery of dystrophin as the deficient protein].
    Kunze D; Rüstow B
    Z Med Lab Diagn; 1991; 32(3-4):141-6. PubMed ID: 1897290
    [No Abstract]   [Full Text] [Related]  

  • 45. The muscular dystrophies.
    Dubowitz V
    Postgrad Med J; 1992 Jul; 68(801):500-6. PubMed ID: 1437944
    [No Abstract]   [Full Text] [Related]  

  • 46. Myoblast transplantation.
    Furlong TE
    Science; 1992 Sep; 257(5075):1329. PubMed ID: 1529325
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible.
    Roy R; Tremblay JP; Huard J; Richards C; Malouin F; Bouchard JP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):995-7. PubMed ID: 8442296
    [No Abstract]   [Full Text] [Related]  

  • 48. Myoblast therapy.
    Epstein HF; Fischman DA; Bader D; Changeux JP; Buckhold K; Ordahl CP; Hoffman E; Kedes LH; Konieczny S; Leinwand LA
    Science; 1992 Aug; 257(5071):738. PubMed ID: 1496388
    [No Abstract]   [Full Text] [Related]  

  • 49. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy.
    Law PK; Bertorini TE; Goodwin TG; Chen M; Fang QW; Li HJ; Kirby DS; Florendo JA; Herrod HG; Golden GS
    Lancet; 1990 Jul; 336(8707):114-5. PubMed ID: 1697393
    [No Abstract]   [Full Text] [Related]  

  • 50. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
    Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
    Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblasts fuse with myotubes developing in culture.
    Chaudhari N; Beam KG
    Adv Exp Med Biol; 1990; 280():131-6; discussion 136-7. PubMed ID: 2248133
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice.
    Ragot T; Vincent N; Chafey P; Vigne E; Gilgenkrantz H; Couton D; Cartaud J; Briand P; Kaplan JC; Perricaudet M
    Nature; 1993 Feb; 361(6413):647-50. PubMed ID: 8437625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.
    Tremblay JP; Malouin F; Roy R; Huard J; Bouchard JP; Satoh A; Richards CL
    Cell Transplant; 1993; 2(2):99-112. PubMed ID: 8143083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.
    Matsumura K; Tomé FM; Ionasescu V; Ervasti JM; Anderson RD; Romero NB; Simon D; Récan D; Kaplan JC; Fardeau M
    J Clin Invest; 1993 Aug; 92(2):866-71. PubMed ID: 8349821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Identification of the dystrophin gene deletions in DMD/BMD patients. Analysis of the reading frame shift and germinal mosaicism].
    Covone AE; Caroli F; Cereseto A; Lerone M; Romeo G
    Minerva Pediatr; 1991 Mar; 43(3):65-6. PubMed ID: 1870527
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family.
    Wilton SD; Chandler DC; Kakulas BA; Laing NG
    Hum Mutat; 1994; 3(2):133-40. PubMed ID: 8199594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myoblast transfer and gene therapy in muscular dystrophies.
    Pagel CN; Morgan JE
    Microsc Res Tech; 1995 Apr; 30(6):469-79. PubMed ID: 7599358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The structural and functional diversity of dystrophin.
    Ahn AH; Kunkel LM
    Nat Genet; 1993 Apr; 3(4):283-91. PubMed ID: 7981747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myocardial evidence of dystrophin mosaic in a Duchenne muscular dystrophy carrier.
    Schmidt-Achert M; Fischer P; Pongratz D
    Lancet; 1992 Nov; 340(8829):1235-6. PubMed ID: 1359314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.